Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FETONET: [18F]FET-βAG-TOCA for NET Imaging
NCT06456723Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2014
- Primary completion
- Oct 2018
- Modality
- Peptides
01
Overview
A Phase 2 trial of 18F-FET-bAG-TOCA in neuroendocrine tumors (NETs), sponsored by Imperial College London. Started May 2014; status: completed.
02
Drugs
18F-FET-bAG-TOCA
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT06456723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06456723.